Abstract

The efficacy of chemotherapy is reduced by dysfunctional tumor vasculature, which may limit chemotherapy delivery to tumors. Preclinical studies have shown that moderate aerobic exercise improves tumor vascular function and increases chemotherapy efficacy in mouse models, but the effect of exercise on human tumor vasculature has not yet been determined. Here, we demonstrate that exercise remodels the tumor vasculature, accelerates the regression, and delays the regrowth of pancreatic ductal adenocarcinoma in a patient-derived xenograft mouse model treated with gemcitabine. By evaluating pancreatic adenocarcinoma specimens from patients treated with preoperative chemotherapy or chemoradiation therapy, we also demonstrate for the first time that tumor vascular remodeling occurs in association with exercise in humans. Future studies will evaluate whether exercise-induced vascular remodeling improves gemcitabine or other chemotherapy efficacy in patients, as this study evaluated only changes in tumor vascular structure.

Details

Title
Exercise during preoperative therapy increases tumor vascularity in pancreatic tumor patients
Author
Claudia Alvarez Florez Bedoya 1 ; Ferreira Cardoso, Ana Carolina 2   VIAFID ORCID Logo  ; Parker, Nathan 3 ; Ngo-Huang, An 4   VIAFID ORCID Logo  ; Petzel, Maria Q 5 ; Kim, Michael P 5 ; Fogelman, David 6 ; Romero, Salvador Gabriel 1 ; Wang, Huamin 7 ; Park, Minjeong 8 ; Katz, Matthew H G 5 ; Schadler, Keri L 1 

 Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 
 Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Departmento de Radiologia e Oncologia, Faculdade de Medicina, Centro de Investigacao Translacional em Oncolgia, Instituto do Cancer do Estado de Sao Paulo, Universidade de Sao Paulo, Sao Paulo, Brazil 
 Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 
 Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 
 Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 
 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 
 Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 
 Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 
Pages
1-8
Publication year
2019
Publication date
Sep 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2298761692
Copyright
© 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.